The scope of pharmacy practice in Australia has expanded considerably over the past decade. Pharmacists are now delivering vaccinations, conducting health assessments, providing medication management reviews, and in many jurisdictions, prescribing for an expanding range of conditions. The profession has responded to healthcare system demands with professionalism and capability, absorbing new responsibilities while maintaining the quality of care that patients rely on. By any reasonable measure, pharmacies are doing more than they have ever done.
More Responsibility, the Same Structural Constraints
What has not changed at the same pace is the structural environment in which that expanded practice operates. The physical model of pharmacy — fixed trading hours, staff-dependent service delivery, counter-based interactions — remains largely as it was when the scope of practice was considerably narrower. The result is a profession that is being asked to do more within a framework that was not designed for the volume or variety of what is now expected of it.
This creates a particular kind of pressure. It is not the pressure of incompetence or inadequacy. It is the pressure of a capable profession operating at the edge of a model that has not kept pace with its own growth. Pharmacists and pharmacy staff are working harder and delivering more — and yet the sense that the workload is manageable, that the day is under control, that capacity exists to absorb the next demand, is increasingly difficult to sustain.
Where the Model Starts to Strain
The strain shows up in predictable places. Dispensing queues that lengthen during peak periods. Clinical consultations that are interrupted by counter demands. After-hours calls that cannot be answered. Patient needs that arise outside trading hours and go unmet not because the pharmacist is unwilling but because the model does not accommodate them. These are not isolated failures. They are structural consequences of a model that was designed for a different era.
The expansion of pharmacy's clinical role has been a genuine achievement. But it has also, in some respects, made the access problem more visible. When a pharmacist is conducting a medication review or a vaccination clinic, they are not available at the counter. When trading hours end, the clinical capability ends with them. The profession has grown; the window through which patients can access it has not.
The Model Is Being Stretched — Not Failing
It is important to be precise about what this means. The pharmacy model is not failing. The profession is not in crisis. What is happening is that a model built for a particular set of demands is being asked to accommodate a different and larger set of demands without the structural changes that would make that accommodation sustainable.
The response to this kind of pressure is not to work harder within the existing model. It is to examine whether the model itself needs to evolve. The profession has already demonstrated its capacity to expand its clinical role. The next question is whether the infrastructure through which that role is delivered can expand with it — not to replace what pharmacists do, but to extend the conditions under which patients can access what pharmacists have already prepared and authorised.
Doing more is not the same as doing it sustainably. The model needs to keep pace with the profession.
